Venus Remedies Limited Cyclophosphamide Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Cyclophosphamide Export Records India — #4 Exporter, 13 Shipments, $492.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cyclophosphamide

India Pharmaceutical Trade Intelligence

$19.5M259 Suppliers114 CountriesHS 30049041

ExportsIndia → UNITED STATES83.8%India → ETHIOPIA2.3%

ImportsUNITED STATES → India$592.7K CANADA → India$11.9K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Venus Remedies Limited — Cyclophosphamide Exporter #4 | $492.4K Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Cyclophosphamide Exporter Profile

Indian Pharmaceutical Exporter · #4 for Cyclophosphamide · $492.4K export value · DGFT Verified

Venus Remedies Limited is the #4 Indian exporter of Cyclophosphamide with $492.4K in export value and 13 verified shipments. Venus Remedies Limited holds a 2.5% market share in Cyclophosphamide exports across 5 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Cyclophosphamide Export Profile: Buyers & Destinations

Venus Remedies Limited Cyclophosphamide export treemap — buyers and destination countries | TransData Nexus

Where Does Venus Remedies Limited Export Cyclophosphamide?

Country	Value	Shipments	Share
ETHIOPIA	$197.5K	5	78.7%
ZIMBABWE	$19.1K	2	7.6%
VENEZUELA	$17.6K	2	7.0%
TANZANIA	$16.8K	2	6.7%
PHILIPPINES

Who Are the Top Buyers of Cyclophosphamide from Venus Remedies Limited?

Buyer	Country	Value	Orders
COMMERCIAL BANK	ETHIOPIA	$197.5K	5
P P & C P L	ZIMBABWE	$19.1K	2
CASA DE REPRESENTACION BC	VENEZUELA	$17.6K	2
K P L	TANZANIA	$16.8K	2
2MG I	PHILIPPINES	$1	2

Venus Remedies Limited supplies Cyclophosphamide to 5 buyers globally. The largest buyer is COMMERCIAL BANK (ETHIOPIA), followed by P P & C P L (ZIMBABWE) and CASA DE REPRESENTACION BC (VENEZUELA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cyclophosphamide Formulations Does Venus Remedies Limited Export?

Product Description / Formulation	Value	Shipments
CYCLOPHOSPHAMIDE FOR INJECTION USP 1G	$100.0K	2
CYCLOPHOSPHAMIDE FOR INJECTION USP 1G (	$50.0K	1
CYCLOPHOSPHAMIDE FOR INJECTION 500MG BN.	$23.8K	1
CYCLOPHOSPHAMIDE 500MG CYCLOPHOSPHAMIDEFOR INJ USP 500MG B N X3BM011A MFG DT 02 2023 EXP DT 01 2025	$23.8K	1
CYCLOPHOSPHAMIDE 500 MG CYCLOPHOSPHAMIDEFOR INJECTION USP 500 MG	$11.3K	1
CYCLOPHOSPHAMIDE FOR INJECTION USP 1G (E	$11.3K	1
CYCLOPHOSPHAMIDE FOR INJ. USP 1G.CYCLOPHOSPHAMIDE 1GM.BATCH NO.X4CCC012A,MFG.DT.03/2024, EXP.DT. 02/2026	$9.1K	1
CYCLOPHOSPHAMIDE FOR INJECTION USP 500MGCYCLOPHOSPHAMIDE 500MG ( B.NO.X3KCC021AMD.11/2023 ED.10/2025	$7.8K	1
CYCLOPHOSPHAMIDE 1G CYCLOPHOSPHAMIDE FORINJ.USP 1G ( BATCH NO. X4CCC012B X4CCC022A MD.03/2024 ED.02/2026	$7.7K	1
CYCLOPHOSPHAMIDE FOR INJECTION USP 500MG	$6.3K	1

Venus Remedies Limited exports 12 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYCLOPHOSPHAMIDE FOR INJECTION USP 1G with 2 shipments worth $100.0K.

How Does Venus Remedies Limited Compare to Nearest Cyclophosphamide Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	ALEMBIC PHARMACEUTICALS LIMITED	$850.4K	30	1	$28.3K
1	CIPLA LIMITED	$550.0K	11	1	$50.0K
4	VENUS REMEDIES LIMITED ★	$492.4K	13	5	$37.9K
5	SP ACCURE LABS PRIVATE LIMITED	$272.7K	22	5	$12.4K
6	GETWELL PHARMACEUTICALS	$241.8K	94	9	$2.6K

Venus Remedies Limited ranks #4 among 259 Indian Cyclophosphamide exporters. Average shipment value of $37.9K compared to the market average of $17.9K. The closest competitors by value are ALEMBIC PHARMACEUTICALS LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Cyclophosphamide Exports?

Port	Shipments	% Share
SAHAR AIR	561	26.5%
SAHAR AIR CARGO ACC (INBOM4)	442	20.9%
DELHI AIR	246	11.6%
DELHI AIR CARGO ACC (INDEL4)	189	8.9%
Bombay Air	154	7.3%
Delhi Air	51	2.4%
Bombay Air Cargo	51	2.4%
HYDERABAD AIR	36	1.7%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Cyclophosphamide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 13 individual customs records matching Venus Remedies Limited exporting Cyclophosphamide, covering 12 formulations to 5 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 114+ countries, 518+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cyclophosphamide

Cyclophosphamide

Venus Remedies Limited — Cyclophosphamide Exporter Profile

Venus Remedies Limited — Cyclophosphamide Export Profile: Buyers & Destinations

Where Does Venus Remedies Limited Export Cyclophosphamide?

Who Are the Top Buyers of Cyclophosphamide from Venus Remedies Limited?

What Is India's Total Cyclophosphamide Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Cyclophosphamide Exports?

How Does Venus Remedies Limited Compare to Other Indian Cyclophosphamide Exporters?

What Cyclophosphamide Formulations Does Venus Remedies Limited Export?

How Does Venus Remedies Limited Compare to Nearest Cyclophosphamide Exporters?

Which Indian Ports Ship Cyclophosphamide Exports?

What Other Oncology Products Does Venus Remedies Limited Export?

Cyclophosphamide — Export Intelligence Video

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Cyclophosphamide Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cyclophosphamide Export Data from Venus Remedies Limited

Cyclophosphamide Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source